What is West Pharmaceutical Services Inc worth?
With the base-case assumptions below, a discounted cash flow model on West Pharmaceutical Services Inc's reported free cash flow gives $139.80 per share. The share price was $370.44 on September 25, 2026, 165% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 2.5% | 10.0% | $88.43 | -76% |
| Base | 7.5% | 9.0% | $139.80 | -62% |
| Bull | 12.5% | 8.0% | $242.22 | -35% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $177.98 | $189.67 | $203.95 | $221.81 | $244.76 |
| 8.0% | $149.46 | $157.04 | $166.00 | $176.75 | $189.89 |
| 9.0% | $128.64 | $133.82 | $139.80 | $146.78 | $155.02 |
| 10.0% | $112.78 | $116.47 | $120.64 | $125.42 | $130.93 |
| 11.0% | $100.32 | $103.03 | $106.04 | $109.44 | $113.29 |
Where the presets come from
Base: years 1 to 5 grow at West Pharmaceutical Services Inc's revenue growth rate over the last 5 fiscal years (7.4% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions